170 related articles for article (PubMed ID: 12600961)
1. Low-positive anti-hepatitis C virus enzyme immunoassay results: an important predictor of low likelihood of hepatitis C infection.
Dufour DR; Talastas M; Fernandez MD; Harris B; Strader DB; Seeff LB
Clin Chem; 2003 Mar; 49(3):479-86. PubMed ID: 12600961
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of hepatitis C virus in Brazilian blood donors using a reverse transcriptase nested polymerase chain reaction: comparison with enzyme immunoassay and recombinant protein immunoblot assay.
Gonçales NS; Costa FF; Vassallo J; Gonçales FL
Rev Inst Med Trop Sao Paulo; 2000; 42(5):263-7. PubMed ID: 11058936
[TBL] [Abstract][Full Text] [Related]
3. The Role of the Signal-to-Cutoff Ratio in Automated Anti-HCV Chemiluminescent Immunoassays by Referring to the Nucleic Acid Amplification Test and the Recombinant Immunoblot Assay.
Choi MS; Lee K; Hong YJ; Song EY; Kim DS; Song J
Ann Lab Med; 2018 Sep; 38(5):466-472. PubMed ID: 29797818
[TBL] [Abstract][Full Text] [Related]
4. [Guideline for interpretation and report of the antibody to hepatitis C virus. Grupo de Desarrollo de la Guía ].
Contreras AM; Ochoa-Jiménez RJ; Kershenobich D; Granados-García V; Conde-González CJ; Celis A; Pérez-Gómez HR; Ruelas-Hernández S; Romero-Flores P; Alcántar-Luna E; Sierra-García de Quevedo J; Ancona-Pisté O;
Rev Invest Clin; 2012; 64(6 Pt 2):641-78. PubMed ID: 23593783
[TBL] [Abstract][Full Text] [Related]
5. Age, sex and transaminase dependency of specific and nonspecific results from enzyme immunoassays for antibodies to hepatitis C virus and follow-up of blood donors.
Caspari G; Gerlich WH; Beyer J; Schmitt H
Infusionsther Transfusionsmed; 1995 Aug; 22(4):208-19. PubMed ID: 7496119
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up of and infectivity in blood donors with hepatitis C antibodies and persistently normal alanine aminotransferase levels.
Rossini A; Gazzola GB; Ravaggi A; Agostinelli E; Biasi L; Albertini A; Radaeli E; Cariani E
Transfusion; 1995 Feb; 35(2):108-11. PubMed ID: 7529954
[TBL] [Abstract][Full Text] [Related]
7. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection.
Conry-Cantilena C; VanRaden M; Gibble J; Melpolder J; Shakil AO; Viladomiu L; Cheung L; DiBisceglie A; Hoofnagle J; Shih JW
N Engl J Med; 1996 Jun; 334(26):1691-6. PubMed ID: 8637513
[TBL] [Abstract][Full Text] [Related]
8. Lookback on donors who are repeatedly reactive on first-generation hepatitis C virus assays:justification and rational implementation.
Tobler LH; Tegtmeier G; Stramer SL; Quan S; Dockter J; Giachetti C; Busch MP
Transfusion; 2000 Jan; 40(1):15-24. PubMed ID: 10644807
[TBL] [Abstract][Full Text] [Related]
9. Supplementary anti-hepatitis C virus (HCV) testing with 2nd and 3rd generation recombinant immunoblot assay and matrix applied to enzyme immunoassay positive sera and comparison with HCV-RNA detection.
Engel PM; Dennin RH
Zentralbl Bakteriol; 1998 Oct; 288(2):267-75. PubMed ID: 9809407
[TBL] [Abstract][Full Text] [Related]
10. Non-specific and specific anti-HCV results correlated to age, sex, transaminase, rhesus blood group and follow-up in blood donors.
Caspari G; Gerlich WH; Beyer J; Schmitt H
Arch Virol; 1997; 142(3):473-89. PubMed ID: 9349294
[TBL] [Abstract][Full Text] [Related]
11. Detection of anti-hepatitis C virus antibodies in patients undergoing dialysis by utilizing a hepatitis C virus 3.0 assay: correlation with hepatitis C virus RNA.
de Medina M; Hill M; Sullivan HO; Leclerq B; Pennell JP; Jeffers L; Reddy KR; Schiff ER; Perez GO
J Lab Clin Med; 1998 Jul; 132(1):73-5. PubMed ID: 9665375
[TBL] [Abstract][Full Text] [Related]
12. Significance of the signal-to-cutoff ratios of anti-hepatitis C virus enzyme immunoassays in screening of Chinese blood donors.
Ren FR; Lv QS; Zhuang H; Li JJ; Gong XY; Gao GJ; Liu CL; Wang JX; Yao FZ; Zheng YR; Zhu FM; Tiemuer MH; Bai XH; Shan H
Transfusion; 2005 Nov; 45(11):1816-22. PubMed ID: 16271110
[TBL] [Abstract][Full Text] [Related]
13. The significance of third-generation HCV RIBA-indeterminate, RNA-negative results in voluntary blood donors screened with sequential third-generation immunoassays.
Kiely P; Kay D; Parker S; Piscitelli L
Transfusion; 2004 Mar; 44(3):349-58. PubMed ID: 14996191
[TBL] [Abstract][Full Text] [Related]
14. Indeterminate RIBA results were associated with the absence of hepatitis C virus RNA (HCV-RNA) in blood donors.
Pereira FM; Zarife MA; Reis EA; G Reis M
Rev Soc Bras Med Trop; 2014; 47(1):12-7. PubMed ID: 24603731
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of biochemical, hematological, RIBA and PCR assays in predicting viremia in anti-HCV positive patients.
Sirin MC; Cicioglu Aridogan B; Sesli Cetin E; Sirin FB
J Infect Dev Ctries; 2019 Aug; 13(8):736-743. PubMed ID: 32069258
[TBL] [Abstract][Full Text] [Related]
16. Is it possible to diagnose acute hepatitis C virus (HCV) infection by a rising anti-HCV titre rather than by seroconversion?
Lu SN; Tung HD; Chen TM; Lee CM; Wang JH; Hung CH; Chen CH; Changchien CS
J Viral Hepat; 2004 Nov; 11(6):563-70. PubMed ID: 15500558
[TBL] [Abstract][Full Text] [Related]
17. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy.
Guadagnino V; Stroffolini T; Rapicetta M; Costantino A; Kondili LA; Menniti-Ippolito F; Caroleo B; Costa C; Griffo G; Loiacono L; Pisani V; Focà A; Piazza M
Hepatology; 1997 Oct; 26(4):1006-11. PubMed ID: 9328327
[TBL] [Abstract][Full Text] [Related]
18. Detection of hepatitis C virus (HCV) RNA by PCR related to HCV antibodies in serum and liver histology in Swedish blood donors.
Yun ZB; Lindh G; Weiland O; Johansson B; Sönnerborg A
J Med Virol; 1993 Jan; 39(1):57-61. PubMed ID: 7678638
[TBL] [Abstract][Full Text] [Related]
19. Performance of hepatitis C virus (HCV) antibody test systems in relation to HCV-RNA detection in the diagnosis of HCV infection.
Krarup HB; Jacobsen SE; Varming K; Drewes AM; Madsen PH
Dan Med Bull; 1998 Feb; 45(1):89-91. PubMed ID: 9504268
[TBL] [Abstract][Full Text] [Related]
20. Use of overlapping synthetic peptides to characterize samples from blood donors with indeterminate results to hepatitis C virus core antigen.
León P; López JA; Elola C; Lee SR; Calmann M; Echevarría JM
Vox Sang; 1998; 75(1):32-6. PubMed ID: 9745151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
